756 related articles for article (PubMed ID: 16419627)
1. Increasing amniotic fluid magnesium concentrations with stable maternal serum levels: a prospective clinical trial.
Gortzak-Uzan L; Mezad D; Smolin A; Friger M; Huleihel M; Hallak M
J Reprod Med; 2005 Nov; 50(11):817-20. PubMed ID: 16419627
[TBL] [Abstract][Full Text] [Related]
2. Fetal serum and amniotic fluid magnesium concentrations with maternal treatment.
Hallak M; Berry SM; Madincea F; Romero R; Evans MI; Cotton DB
Obstet Gynecol; 1993 Feb; 81(2):185-8. PubMed ID: 8423946
[TBL] [Abstract][Full Text] [Related]
3. Intravenous magnesium sulphate effect on maternal serum and amniotic fluid cytokines levels in preterm labour patients.
Mezad D; Hallak M; Huleihel M; Gortzak-Uzan L; Smolin A; Mazor M
Magnes Res; 2002 Dec; 15(3-4):247-52. PubMed ID: 12635880
[TBL] [Abstract][Full Text] [Related]
4. Are amniotic fluid C-reactive protein and glucose levels, and white blood cell counts at the time of genetic amniocentesis related with preterm delivery?
Tarim E; Bağiş T; Kiliçdağ EB; Sezgin N; Yanik F
J Perinat Med; 2005; 33(6):524-9. PubMed ID: 16318616
[TBL] [Abstract][Full Text] [Related]
5. Serum ionized magnesium during magnesium sulfate administration for preterm labor and preeclampsia.
Yoshida M; Matsuda Y; Akizawa Y; Ono E; Ohta H
Eur J Obstet Gynecol Reprod Biol; 2006; 128(1-2):125-8. PubMed ID: 16337073
[TBL] [Abstract][Full Text] [Related]
6. Magnesium sulfate tocolysis and pulmonary edema: the drug or the vehicle?
Samol JM; Lambers DS
Am J Obstet Gynecol; 2005 May; 192(5):1430-2. PubMed ID: 15902128
[TBL] [Abstract][Full Text] [Related]
7. A prospective, randomized, controlled trial of high and low maintenance doses of magnesium sulfate for acute tocolysis.
Terrone DA; Rinehart BK; Kimmel ES; May WL; Larmon JE; Morrison JC
Am J Obstet Gynecol; 2000 Jun; 182(6):1477-82. PubMed ID: 10871468
[TBL] [Abstract][Full Text] [Related]
8. The effects of maternal magnesium sulfate treatment on newborns: a prospective controlled study.
Riaz M; Porat R; Brodsky NL; Hurt H
J Perinatol; 1998; 18(6 Pt 1):449-54. PubMed ID: 9848759
[TBL] [Abstract][Full Text] [Related]
9. Rofecoxib versus magnesium sulfate to arrest preterm labor: a randomized trial.
McWhorter J; Carlan SJ; OLeary TD; Richichi K; OBrien WF
Obstet Gynecol; 2004 May; 103(5 Pt 1):923-30. PubMed ID: 15121566
[TBL] [Abstract][Full Text] [Related]
10. Relationship between uterine contractions and serum magnesium levels in patients treated for threatened preterm labour with intravenous magnesium sulphate.
Lurie S; Gur D; Sadan O; Glezerman M
J Obstet Gynaecol; 2004 Apr; 24(3):247-8. PubMed ID: 15203617
[TBL] [Abstract][Full Text] [Related]
11. Serum magnesium levels during magnesium sulfate tocolysis in high-order multiple gestations.
Elliott JP; Radin TG
J Reprod Med; 1995 Jun; 40(6):450-2. PubMed ID: 7650659
[TBL] [Abstract][Full Text] [Related]
12. Celecoxib versus magnesium sulfate to arrest preterm labor: randomized trial.
Borna S; Saeidi FM
J Obstet Gynaecol Res; 2007 Oct; 33(5):631-4. PubMed ID: 17845320
[TBL] [Abstract][Full Text] [Related]
13. Differences in amniotic fluid and maternal serum cytokine levels in early midtrimester women without evidence of infection.
Chow SS; Craig ME; Jones CA; Hall B; Catteau J; Lloyd AR; Rawlinson WD
Cytokine; 2008 Oct; 44(1):78-84. PubMed ID: 18703348
[TBL] [Abstract][Full Text] [Related]
14. Maternal magnesium level effect on preterm labor treatment.
Uludağ EÜ; Gözükara IÖ; Kucur SK; Uluğ P; Özdeğirmenci Ö; Erkaya S
J Matern Fetal Neonatal Med; 2014 Sep; 27(14):1449-53. PubMed ID: 24156667
[TBL] [Abstract][Full Text] [Related]
15. Elevated mid-trimester amniotic fluid ADAM-8 concentrations as a potential risk factor for preterm delivery.
Vrachnis N; Malamitsi-Puchner A; Samoli E; Botsis D; Iliodromiti Z; Baka S; Hassiakos D; Creatsas G
J Soc Gynecol Investig; 2006 Apr; 13(3):186-90. PubMed ID: 16638589
[TBL] [Abstract][Full Text] [Related]
16. Magnesium sulfate compared with nifedipine for acute tocolysis of preterm labor: a randomized controlled trial.
Lyell DJ; Pullen K; Campbell L; Ching S; Druzin ML; Chitkara U; Burrs D; Caughey AB; El-Sayed YY
Obstet Gynecol; 2007 Jul; 110(1):61-7. PubMed ID: 17601897
[TBL] [Abstract][Full Text] [Related]
17. Blunted fetal response to vibroacoustic stimulation associated with maternal intravenous magnesium sulfate therapy.
Sherer DM
Am J Perinatol; 1994 Nov; 11(6):401-3. PubMed ID: 7857429
[TBL] [Abstract][Full Text] [Related]
18. Adverse maternal and neonatal outcome of prolonged course of magnesium sulfate tocolysis.
Nassar AH; Sakhel K; Maarouf H; Naassan GR; Usta IM
Acta Obstet Gynecol Scand; 2006; 85(9):1099-103. PubMed ID: 16929415
[TBL] [Abstract][Full Text] [Related]
19. Intravenous maternal hydration in third trimester oligohydramnios: effect on amniotic fluid volume.
Umber A; Chohan MA
J Coll Physicians Surg Pak; 2007 Jun; 17(6):336-9. PubMed ID: 17623581
[TBL] [Abstract][Full Text] [Related]
20. Mid-trimester amniotic fluid C-reactive protein, ferritin and lactate dehydrogenase concentrations and subsequent risk of spontaneous preterm labour.
Borna S; Mirzaie F; Abdollahi A
Aust N Z J Obstet Gynaecol; 2009 Aug; 49(4):400-3. PubMed ID: 19694695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
